We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

900947:SSEShanghai Zhenhua Heavy Industries Co., Ltd. Class B Analysis

Data as of 2026-06-02 - not real-time

$0.25

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Shanghai Zhenhua Heavy Industries trades at a deep discount to its discounted cash‑flow estimate, with a market price around $0.25 versus a fair value of roughly $5.3, suggesting significant upside potential. Fundamentally, the company delivers a solid dividend yield of over 4% and a payout ratio under 50%, while maintaining positive operating and free cash flow, though its debt‑to‑equity ratio exceeds 100%, indicating leverage concerns. Technically, the 20‑day and 50‑day SMAs are virtually flat, the RSI sits just below 40, and the MACD histogram is negative, pointing to modest bearish momentum, while volume has been trending downwards. The stock is hovering near a support level of $0.25 and faces resistance around $0.272, with a neutral overall trend and low beta of 0.18, implying limited price volatility relative to the market.
Given the extreme greed sentiment in the broader market, the combination of attractive valuation, high dividend yield, and low systematic risk makes the stock a compelling value play, but investors should remain mindful of the high leverage, sector cyclicality, and decreasing liquidity.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near immediate support at $0.25
  • Bearish MACD histogram
  • Decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value far exceeds current price
  • High dividend yield with sustainable payout
  • Low beta and modest volatility

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term infrastructure and port equipment demand
  • Elevated debt level requiring monitoring
  • Consistent cash flow generation supporting dividends

Key Metrics & Analysis

Financial Health

Revenue Growth0.90%
Profit Margin2.35%
P/E Ratio12.7
ROE5.81%
ROA1.08%
Debt/Equity102.71
P/B Ratio0.6
Op. Cash Flow$4.9B
Free Cash Flow$3.2B
Industry P/E29.8

Technical Analysis

TrendNeutral
RSI38.9
Support$0.25
Resistance$0.27
MA 20$0.26
MA 50$0.26
MA 200$0.27
MACDBearish
VolumeDecreasing
Fear & Greed Index92.63

Valuation

Fair Value$5.29
GradeUndervalued
TypeValue
Dividend Yield4.12%

Risk Assessment

Beta0.18
Volatility21.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.